Showing results (81-90 of 145) with videos related to
Sort By:
Pageof 15
Neurology|July 1, 2021
Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple SclerosisIzanne Roos, Emmanuelle Leray, Romain Casey, et al.Multiple Sclerosis and Related Disorders|December 20, 2025
Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-studyHelmut Butzkueven, Pamela Farr, Serkan Ozakbas, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2022
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registryTim Spelman, Serkan Ozakbas, Raed Alroughani, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 19, 2022
Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosisChao Zhu, Zhen Zhou, Izanne Roos, et al.Neurodegenerative Disease Management|June 8, 2023
A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registryTim Spelman, Serkan Ozakbas, Raed Alroughani, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 30, 2022
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registrySifat Sharmin, Charles B Malpas, Izanne Roos, et al.Journal of Neurology|April 14, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort studyPakeeran Siriratnam, Saif Huda, Anneke Van der Walt, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2024
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre studyPakeeran Siriratnam, Paul Sanfilippo, Anneke van der Walt, et al.Neurology|November 19, 2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSDPakeeran Siriratnam, Saif Huda, Anneke Van Der Walt, et al.Journal of the Neurological Sciences|September 19, 2021
Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registryRachel Kenney, Mengling Liu, Sachi Patil, et al.Pageof 15